echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > The State Food and Drug Administration Revises Rats for Injection

    The State Food and Drug Administration Revises Rats for Injection

    • Last Update: 2021-05-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On March 23, the State Food and Drug Administration issued an announcement on revising the instructions for mouse nerve growth factor for injection, and decided to revise the instructions for mouse nerve growth factor for injection [adverse reactions], [precautions] and medications for special populations.
    Among them,
    [Note] stressed that the increase "should be strictly in accordance with the instructions provided for the use of dose administration is strictly prohibited to change the route of administration.
    "

    [Note] stressed that the increase "should be strictly in accordance with the instructions prescribed dosage administered strictly forbidden to change the route of administration.
    "

    annex:

    Revision requirements of the instructions for mouse nerve growth factor for injection

    Revision requirements of the instructions for mouse nerve growth factor for injection

    [Adverse reactions] should include the following:

    Systemic diseases and various reactions at the administration site: fever, chills, chest tightness, fatigue, peripheral edema; pain at the injection site, rash at the injection site, induration at the injection site, swelling at the injection site, itching at the injection site, pain in the lower extremity of the injection side, etc.

    Skin and subcutaneous tissue diseases: itching, maculopapular rash, urticaria, erythema, etc.
    There are case reports of toxic epidermal necrolysis.

    Neuropsychiatric diseases: dizziness, headache, local numbness, limb tremor, convulsions, insomnia, excitement, sleep disorders, mental disorders, etc.

    Gastrointestinal diseases: nausea, vomiting, abdominal pain, diarrhea and other gastrointestinal reactions, elevated transaminase, abnormal liver function.

    Various musculoskeletal and connective tissue diseases: muscle pain, etc.

    Immune system diseases: allergic-like reactions, anaphylactic shock, etc.

    Others: conjunctival hyperemia, palpitations, arrhythmia, dyspnea, laryngeal edema, granulocytosis, thrombocytosis, abnormal renal function, etc.

    【Precautions】

    Increase "should be strictly predetermined according to the use amount of administration instructions.
    Prohibited to change the
    route of administration.
    "

    Medicine route.
    "

    [Medicine for pregnant women and lactating women]

    The expressions "this product has the effect of promoting growth and development on the nervous system" and "please follow the doctor's advice" are deleted, and the content related to this special group of people is reserved.

    【Children's Medication】

    Only keep the relevant statements that there are no medication data for children.
    If there is "Children's medication please follow the doctor's advice" in this item, please delete it.

    (Note: If the other contents of the manual are inconsistent with the above revision requirements, they should be revised together.
    )

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.